Concord Medical Services Holdings (CCM) Research & Development (2011 - 2025)

Concord Medical Services Holdings (CCM) has reported Research & Development for 15 consecutive years, with -$6.7 million the latest figure, recorded in Q2 2025.

• Research & Development for Q2 2025 came in at -$6.7 million, up 44.01% year-over-year; the trailing twelve-month figure through Jun 2025 was $8.0 million (down 76.97% YoY), and the FY2015 annual result was $92.3 million, down 5.66% from the prior year.
• Research & Development was -$6.7 million for Q2 2025 at Concord Medical Services Holdings, up from -$11.9 million in the prior quarter.
• Over five years, Research & Development peaked at $19.9 million in Q2 2021 and troughed at -$11.9 million in Q2 2024.
• Average Research & Development over 5 years is $5.6 million, with a median of $9.2 million recorded in 2022.
• Year-over-year, Research & Development jumped 273.95% in 2021 and slumped 168.56% in 2024.
• Over 5 years, Research & Development stood at $19.9 million in 2021, then slumped by 54.03% to $9.2 million in 2022, then soared by 89.28% to $17.3 million in 2023, then plunged by 168.56% to -$11.9 million in 2024, then surged by 44.01% to -$6.7 million in 2025.
• Per Business Quant data, the three most recent Research & Development figures were -$6.7 million in Q2 2025, -$11.9 million in Q2 2024, and $17.3 million in Q2 2023.